Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 7, 2026; 32(21): 116337
Published online Jun 7, 2026. doi: 10.3748/wjg.v32.i21.116337
Published online Jun 7, 2026. doi: 10.3748/wjg.v32.i21.116337
Table 4 Secondary antibodies used in the study
| Antigen | Conjugation | Dilution | Source | Catalog No. |
| Donkey anti-rabbit IgG | Alexa flour 488 | 1:1000 | Invitrogen (Carlsbad, CA, United States) | A21206 |
| Donkey anti-rabbit IgG | Alexa flour 594 | 1:1000 | Invitrogen (Carlsbad, CA, United States) | A21207 |
| Donkey anti-chicken IgG | Alexa flour 488 | 1:1000 | Jackson (Lancaster, PA, United States) | 703545155 |
| Goat anti-rabbit IgG | HRP | 1:5000 | Abcam (Cambridge, United Kingdom) | AB9655 |
- Citation: Li Y, Tao SS, Wang Y, Sun Q, Li MY, Zhang H, Li YQ. Salidroside mitigates experimental colitis through cyclic adenosine monophosphate pathway activation and suppression of enteric glial cell responses. World J Gastroenterol 2026; 32(21): 116337
- URL: https://www.wjgnet.com/1007-9327/full/v32/i21/116337.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i21.116337